Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preductal OD add-on to bisoprolol in adults with stable angina
ISRCTN29992579Phase 4Completed
- Sponsor
- Servier
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of trimetazidine in coronary arteriosclerosis and stable angina, sponsored by Servier. Primary endpoints: Number of angina attacks per week and Number of consumed short-acting nitroglycerin preparations per week. Started Dec 2017; status: completed.
02
Drugs
trimetazidine
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ISRCTN29992579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29992579.